Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

HIKMA

  • FDA Approval
  • Nov. 29, 2022, 12:41 UTC
  • 21
  • 0 comments

FDA approve PROCHLORPERAZINE EDISYLATE

Comment Full text

ALVOGEN

  • FDA Approval
  • Nov. 29, 2022, 12:41 UTC
  • 25
  • 0 comments

FDA approve BUPRENORPHINE

Comment Full text

SUN PHARM INDS LTD

  • FDA Approval
  • Nov. 29, 2022, 12:41 UTC
  • 26
  • 0 comments

FDA approve LOPERAMIDE HYDROCHLORIDE; SIMETHICONE

Comment Full text

CADILA PHARMS LTD

  • FDA Approval
  • Nov. 29, 2022, 12:41 UTC
  • 27
  • 0 comments

FDA approve ERYTHROMYCIN ETHYLSUCCINATE

Comment Full text

RISING

  • FDA Approval
  • Nov. 29, 2022, 12:41 UTC
  • 28
  • 0 comments

FDA approve ZOLPIDEM TARTRATE

Comment Full text

SANDOZ

  • FDA Approval
  • Nov. 29, 2022, 12:41 UTC
  • 28
  • 0 comments

FDA approve ZOLPIDEM TARTRATE

Comment Full text

ALKEM LABS LTD

  • FDA Approval
  • Nov. 29, 2022, 12:41 UTC
  • 27
  • 0 comments

FDA approve VENLAFAXINE HYDROCHLORIDE

Comment Full text

BRECKENRIDGE

  • FDA Approval
  • Nov. 29, 2022, 12:41 UTC
  • 28
  • 0 comments

FDA approve ZOLPIDEM TARTRATE

Comment Full text

CADILA PHARMS LTD

  • FDA Approval
  • Nov. 29, 2022, 12:41 UTC
  • 26
  • 0 comments

FDA approve VENLAFAXINE HYDROCHLORIDE

Comment Full text

BRISTOL MYERS SQUIBB

  • FDA Approval
  • Nov. 29, 2022, 12:38 UTC
  • 27
  • 0 comments

FDA approve IPILIMUMAB

Comment Full text
  • Previous
  • 931
  • 932
  • 933
  • 934
  • 935
  • Next

Search

News categories

  • Technical Exchange News(12316)
  • Event(6229)
  • SEC News(267870)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(156157)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin